B16-OVA tumor-bearing mice treated with checkpoint inhibitors and SLA–OVA had the highest numbers of CD45+ cells (Figure 3G) and CD8+ cells and these cells were found close to dying or dead tumor cells (Figure 3H) and were widely dispersed throughout the viable tumor tissue (Figure 3I). Here, CD8A is linked to neoplasm.